ASA. S. Shubina

A. S. Shubina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. S. Shubina has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of Pregnancy on Long-Term Treatment Outcomes in Reproductive-Age Patients with Melanoma

    by V. V. Petkau, E. P. Beloglazova, K. E. Kiseleva, M. S. Khankishiev, A. S. Shubina, В. В. Петкау, Е. П. Белоглазова, К. Е. Киселёва, М. С. Ханкишиев, А. С. Шубина

    Introduction . Melanoma remains one of the most aggressive malignant skin tumors, and its association with pregnancy or pregnancy planning after treatment presents a multidisciplinary challenge. Historically, physiological hormonal changes and immunosuppression during pregnancy were thought to stimulate tumor growth, but data analysis adjusted for the leading prognostic factor — Breslow tumor thickness — did not confirm an independent negative impact of pregnancy-related melanoma on overall and relapse-free survival. Purpose of the work is to assess the survival rates of patients in the Sverdlovsk region who became pregnant after treatment for melanoma. Material and methods. A retrospective analysis was conducted using medical records from the “Medoffice” information system, as well as the regional information systems ONKOR and the “Pregnant Women Monitoring Program”. The study included patients who conceived following treatment for cutaneous melanoma; a comparison group was also established, consisting of patients with a histologically confirmed diagnosis — matched for age and tumor TNM characteristics — who did not become pregnant. In total, 41 pregnant patients and 66 patients in the comparison group met the selection criteria. Results. In the subgroup of pregnant patients, 1-, 3-, and 5‑year OS were 100 %, in the comparison group, 1‑year OS was 100 %, 3‑year OS was 97.90 %, and 5‑year OS was 95.35 %. When analyzing the RFS indicators in subgroups among pregnant patients, 1-, 3-, and 5‑year RFS were 100 %, in the comparison group, 1‑year OS was 100 %, 3‑year OS was 93.90 %, and 5‑year OS was 87.20 %. Median OS and RFS were not achieved in any subgroup. Conclusions . Both OS and RFS rates were higher among pregnant patients; the difference was statistically significant for RFS. No association was established between pregnancy and an increased risk of death or recurrence.

  • The Effectiveness of Dermocosmetics for Skin Toxicity in Cancer Patients

    by K.N. Sorokina, M.A. Ufimtseva, A.S. Shubina, T.A. Beresneva, A.M. Chokova

    Relevance. Targeted therapy is a key component of modern chemotherapy algorithms for cancer patients. Specific side effects related to the skin and its derivatives necessitate the study and development of dermatological control methods to preserve cancer therapy volume. Objective. To investigate the effectiveness of zinc-containing emollients and a healing balm in combined treatment of dermatological toxicity in cancer patients receiving EGFR inhibitors. Material and methods. This clinical cross-sectional study involved 115 patients who received cancer therapy with EGFR inhibitors exhibiting skin toxicity, zinc- and copper-containing emollients and a healing balm. The therapy effectiveness and the skin toxicity impact on the patient’s quality of life were assessed using the NCI-CTCAE V5.0 classification, the Visual Analogue Scale (VAS) for Pain, and the Dermatology Life Quality Index (DLQI). Results. The use of zinc-containing emollients and a healing balm for dermatological toxicity promoted a quicker clinical effect, reduced the severity of side effects, and improved the quality of life of cancer patients (DLQI, p<0.05). Conclusion. The clinical effectiveness of zinc-containing emollients and a healing balm allows us to recommend them for treating skin toxicity in cancer patients receiving EGFR inhibitors as monotherapy or combined treatment regimens.

  • To the issue of early diagnosis of malignant skin neoplasms during medical check-ups

    by A.S. Shubina, M.A. Ufimtseva, M.S. Efimova, T.A. Beresneva, N.L. Struin, V.V. Petkau

    Background. Cutaneous melanoma ranks 15th among oncological diseases in the world, and the incidence has a tendency to rise. Active detection of the early stages of melanoma during medical check-ups is important for the favorable prognosis and survival of patients. Objective. To study the indicators of active detection of melanoma and skin cancer on the basis of statistical forms and to describe the clinical cases of late diagnosis of malignant skin neoplasms during medical examinations check-ups. Material and methods. The study of forms of state statistical reporting, approved by order of Federal State Statistics Service (Rosstat) dated December 29, 2011 №520, annual reporting forms of reporting documentation No. 7 and 35 for the 15-year period (2007–2022 yrs.) in the Sverdlovsk Region. A number of clinical cases equal 3 observed among the patients of the SRDVD is given. Results. A low level of active identification of patients with malignant skin neoplasms was recorded for the period from 2007 to 2022 yrs. in the Sverdlovsk Region according to the obtained data. The median proportion of the indicator of active detection of melanoma and skin cancer patients was 25 and 28.7% from the number of identified in the reporting year, respectively. One of the causes for the low detectability of malignant skin neoplasms may be inadequate assessment of the professional factors’ (occupational carcinogens, occupational history) role in the etiology and pathogenesis of tumors development. Conclusion. The development of unified recommendations on the detection and follow-up of patients from risk groups for the emergence of malignant skin neoplasms and the improvement of existing preventive measures aimed at their early diagnosis seem relevant.

  • To the question of melanoma of rare localizations

    by A.S. Shubina, M.A. Ufimtseva, V.V. Petkau, I.F. Vishnevskaya, M.I. Magdaljanova, M.Y. Evdokimov, K.I. Sorokina


  • Open Access

    Interdisciplinary model of patient care for groups at risk for malignant tumors of the skin

    by M. A. Ufimtseva, A. S. Shubina, V. V. Petkau, N. L. Struin, D. E. Emel'JAnov, E. A. Levchenko

    Introduction. Malignant skin tumors (MST) are an important interdisciplinary problem. Neoplasia data refer to tumors of apparent localization, therefore, they are found in the clinical practice of doctors of different profiles. The duration of the diagnostic period, as well as the prognosis, depends on the coordinated work of specialists.Aim. Development, implementation and evaluation of the effectiveness of an interdisciplinary model for managing patients at risk for malignant skin tumors.Materials and methods. A descriptive study included a study of the proportion of people at risk for developing MST, the nosological structure of the revealed MST among patients referred to the dermatological oncology room of the Sverdlovsk Regional Dermatovenerologic Dispensary for the period from 01.01.2016 to 31.12.2017 (total 3,275 patients), as well as 208 patients examined in the Sverdlovsk Regional Oncology Dispensary (SROD). The data of the “ONKOR” regional oncological information system were used.Results. An interdisciplinary model of managing patients at risk has been developed, including patient routing andtraining of specialists in various fields. As a result of the implementation of the model, 208 patients were examined, 208 of whom were diagnosed with skin cancer, 123 of whom had skin cancer, 11 cases of melanoma, Kaposi’s sarcoma in 2 cases, skin lymphomas in 4 patients, lymphosarcoma in 1 patient, amounted to 67.8% of the diagnoses of MST confirmed in the Sverdlovsk Regional Dermatovenerologic Dispensary of the Sverdlovsk Regional Oncology Dispensary. 9.6% of patients had dysplastic nevi, confirmed histologically. 1987 patients at risk of developing MST were taken under the dispensary observation by a dermatologist and venereologist.Conclusion. Тhe introduction of the algorithm of interdisciplinary interaction contributes to the improvement of the quality and accessibility of medical care to the population, the identification of patients at risk for the occurrence of MST, reducing the burden of non-core patients on oncology services.